LONN CH0013841017

Report

Real-time Estimate Cboe Europe - 08/02 06:24:41 am
707.9	CHF		+0.38%

07/29	LONZA : Committee Member Offloads Shares for $1 Million	MT
07/28	LONZA : Credit Suisse Lifts Price Target on Lonza Group, Maintains Outperform Recommendation	MT
07/28	MODERNA : Expects COVID-19 Vaccine Supply Issues To Persist Outside US	MT

Summary

Quotes 5-day view Delayed Quote.

Delayed Swiss Exchange

07/27/2021	07/28/2021	07/29/2021	07/30/2021	08/02/2021	Date
682.6(c)	685.6(c)	692.6(c)	705.2(c)	708.4	Last
168 552	132 729	143 583	198 678	43 569	Volume
-0.50%	+0.44%	+1.02%	+1.82%	+0.45%	Change

More quotes

Estimated financial data (e)

Sales 2021	5 116 M 5 644 M 5 644 M
Net income 2021	789 M 870 M 870 M
Net cash position 2021	51,1 M 56,4 M 56,4 M
P/E ratio 2021	67,1x
Yield 2021	0,44%

Sales 2022	5 763 M 6 358 M 6 358 M
Net income 2022	1 035 M 1 142 M 1 142 M
Net cash position 2022	83,2 M 91,7 M 91,7 M
P/E ratio 2022	50,1x
Yield 2022	0,47%

Capitalization	52 384 M 57 809 M 57 790 M
EV / Sales 2021	10,2x
EV / Sales 2022	9,08x
Nbr of Employees	14 405
Free-Float	99,6%

More Financials

Company

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients.

Sector

Biotechnology & Medical Research

Calendar

09/09

Presentation

More about the company

Ratings of Lonza Group AG

Trading Rating :

Investor Rating :

ESG Refinitiv :

A-

More Ratings

All news about LONZA GROUP AG

07/29	LONZA : Committee Member Offloads Shares for $1 Million	MT
07/28	LONZA : Credit Suisse Lifts Price Target on Lonza Group, Maintains Outperform Re..	MT
07/28	MODERNA : Expects COVID-19 Vaccine Supply Issues To Persist Outside US	MT
07/27	Moderna says COVID-19 vaccine supply outside United States to slow down	RE
07/27	Manufacturing Woes Plague Shipment of Moderna COVID-19 Jab to South Korea	MT
07/27	Moderna says COVID-19 vaccine supply outside United States to slow down	RE
07/26	LONZA : Equita SIM SpA Lifts Price Target on Lonza Group, Maintains Buy Recommen..	MT
07/26	ANALYST RECOMMENDATIONS : Casey's, D.R. Horton, Microsoft, Unilever, Veoneer...
07/23	European Stocks Rally After Dovish ECB Comments, Surge in PMI Services and Ou..	MT
07/23	GLOBAL MARKETS LIVE : Intel, HoneyWell, American Express, Visa, Twitter...
07/23	LONZA : Contemplates Acquisitions to Boost Booming Vaccine Manufacturing Busines..	MT
07/23	LONZA : Half-Year Alternative Performance Measures Report	PU
07/23	Vaccine business helps Lonza lift 2021 sales outlook	RE
07/23	LONZA : H1 Profit Falls as Environmental Provisions Bite Into Revenue Jump	MT
07/23	LONZA : Reports Strong Momentum in H1 2021, with 14.7% CER Sales Growth and 33.3..	PU

More news

News in other languages on LONZA GROUP AG

03:32a	MADRID STOCK EXCHANGE : Recta final antes de la pausa de agosto
02:04a	AVIS D'ANALYSTES DU JOUR : L'Oréal, Renault, Schneider Electric, Valeo, Atos, Bu..
01:05a	STOCK MARKET PARIS : Dernière ligne droite avant la coupure aoûtienne
07/30	Aktien Schweiz gehen etwas fester ins Wochenende
07/30	L'EMA approuve l'augmentation de la production du vaccin Moderna aux Etats-Un..

More news

Analyst Recommendations on LONZA GROUP AG

07/28	LONZA : Credit Suisse Lifts Price Target on Lonza Group, Maintains Outperform Re..	MT
07/26	LONZA : Equita SIM SpA Lifts Price Target on Lonza Group, Maintains Buy Recommen..	MT
07/26	ANALYST RECOMMENDATIONS : Casey's, D.R. Horton, Microsoft, Unilever, Veoneer...

More recommendations

Provided by Scoopnest.com

Analysis

Lonza : completes $4.5 billion specialty ingredients divestment